Clinical characteristics of bone disease in multiple myeloma and clinical significance of monitoring bone metabolic markers

被引：1
|
作者：
褚彬 [1 ]
机构：
[1] Dept Hematol, Beijing Jishuitan Hosp
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2016年 / 33卷 / 03期
关键词：
bone; CTX; PINP;
D O I：
暂无
中图分类号：
R733.3 [骨髓肿瘤];
学科分类号：
摘要：
Objective To observe the clinical characteristics of bone disease in patients with multiple myeloma(MM)and the clinical significance of monitoring bone metabolic markers.Methods The data of 178 MM case newly diagnosed in Beijing Ji Shui Tan Hospital from January 2009to June 2014 were reviewed to analyze the types and classification of bone disease and to observe the clinical char-
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [21] Bone markers in patients with multiple myeloma and monoclonal gammopathy of undetermined significance
    Glendenning, P
    Vasikaran, SD
    INTERNAL MEDICINE JOURNAL, 2002, 32 (1-2) : 56 - 57
  • [22] Clinical use of markers of bone turnover in metastatic bone disease
    Markus J Seibel
    Nature Clinical Practice Oncology, 2005, 2 : 504 - 517
  • [23] Clinical use of markers of bone turnover in metastatic bone disease
    Seibel, MJ
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (10): : 504 - 517
  • [24] BONE-MARROW IMMUNOHISTOCHEMICAL ASSAY IN MULTIPLE-MYELOMA - CLINICAL-SIGNIFICANCE
    RAPAZZINI, P
    BETTINI, R
    RINALDINI, C
    HAEMATOLOGICA, 1988, 73 (02) : 156 - 156
  • [25] Bone disease in multiple myeloma: new markers, new treatments
    Joshua, D
    INTERNAL MEDICINE JOURNAL, 2001, 31 (05) : 261 - 263
  • [26] Markers of bone remodelling in metabolic bone disease
    de Vernejoul, MC
    DRUGS & AGING, 1998, 12 (Suppl 1) : 9 - 14
  • [27] Clinical performances of biochemical markers of bone resorption in metabolic bone diseases.
    Dorizzi, RM
    Bertoldo, F
    Zanini, M
    Caputo, M
    Gasperi, E
    Furlan, F
    CLINICAL CHEMISTRY, 1997, 43 : 636 - 636
  • [28] The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer
    Suna Bilgin Bayrak
    Emel Ceylan
    Mukadder Serter
    Fisun Karadağ
    Ece Demir
    Orhan Çildağ
    International Journal of Clinical Oncology, 2012, 17 : 112 - 118
  • [29] Markers of Bone Remodelling in Metabolic Bone Disease
    Marie-Christine de Vernejoul
    Drugs & Aging, 1998, 12 : 9 - 14
  • [30] The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer
    Bayrak, Suna Bilgin
    Ceylan, Emel
    Serter, Mukadder
    Karadag, Fisun
    Demir, Ece
    Cildag, Orhan
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (02) : 112 - 118
12345